Concerning the possible targets of resveratrol analogs, an inhibition of the TNF alpha-induced activation NFkB by polyhydroxylated resveratrol derivatives i.e., the hexahydroxystilbene in leukemia HL60 cells has been reported [70]. The gene discussed is NFKB1; the disease is leukemia.